Literature DB >> 17408451

Chronic inflammation: a failure of resolution?

Toby Lawrence1, Derek W Gilroy.   

Abstract

Inflammation has evolved as a protective response to insult or injury, it's a primordial response that eliminates or neutralises foreign organisms or material, the resolution of inflammation encompasses the endogenous anti-inflammatory mechanisms that protect us against excessive tissue injury and promote the restoration of tissue structure and function. In fact, our well being and survival depends upon its efficiency and carefully-balanced control. In general, the innate inflammatory response initiates within minutes and, if all is well, resolves within hours. In contrast, chronic inflammation persists for weeks, months or even years. Here, we are going to discuss the key endogenous checkpoints necessary for mounting an effective yet limited inflammatory response and the crucial biochemical pathways necessary to prevent its persistence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408451      PMCID: PMC2517296          DOI: 10.1111/j.1365-2613.2006.00507.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  63 in total

Review 1.  Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets.

Authors:  C Ward; I Dransfield; E R Chilvers; C Haslett; A G Rossi
Journal:  Trends Pharmacol Sci       Date:  1999-12       Impact factor: 14.819

2.  Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.

Authors:  C Godson; S Mitchell; K Harvey; N A Petasis; N Hogg; H R Brady
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.

Authors:  A Rossi; P Kapahi; G Natoli; T Takahashi; Y Chen; M Karin; M G Santoro
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 4.  Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction.

Authors:  Jagan R Muppidi; Jürg Tschopp; Richard M Siegel
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

5.  Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis.

Authors:  J Savill; I Dransfield; N Hogg; C Haslett
Journal:  Nature       Date:  1990-01-11       Impact factor: 49.962

Review 6.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

7.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

Review 8.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

9.  Heme oxygenase: a novel target for the modulation of the inflammatory response.

Authors:  D Willis; A R Moore; R Frederick; D A Willoughby
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

10.  CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis.

Authors:  Y Ren; R L Silverstein; J Allen; J Savill
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  107 in total

1.  Impaired function of Fanconi anemia type C-deficient macrophages.

Authors:  Ying Liu; Kimberly Ballman; Deqiang Li; Shehnaz Khan; Ethel Derr-Yellin; Weinian Shou; Laura S Haneline
Journal:  J Leukoc Biol       Date:  2011-11-21       Impact factor: 4.962

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?

Authors:  Charles N Serhan
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

Review 4.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

5.  Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production.

Authors:  Marion Man-Ying Chan; Andrea Rossi Moore
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

6.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

Review 7.  Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.

Authors:  A E Leitch; C Haslett; A G Rossi
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 8.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

Review 9.  A review of metabolic staging in severely injured patients.

Authors:  Maria-Angeles Aller; Jose-Ignacio Arias; Alfredo Alonso-Poza; Jaime Arias
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-05-17       Impact factor: 2.953

10.  Diminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohn's disease.

Authors:  Christine D Palmer; Farooq Z Rahman; Gavin W Sewell; Afshan Ahmed; Margaret Ashcroft; Stuart L Bloom; Anthony W Segal; Andrew M Smith
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.